This overexpression aims to reduce the inhibitory impact of miR-3142 on GLIS family zinc finger 2 (GLIS2), which in turn prevents the activation of the AKT pathway and thus hinders the progression of lung cancer [117]. The gene discussed is AKT1; the disease is lung carcinoma.